Showing results (131-140 of 160) with videos related to
Sort By:
Pageof 16
Science (New York, N.Y.)|April 24, 2025
Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunityDavid Kung-Chun Chiu, Xiangyue Zhang, Bowie Yik-Ling Cheng, et al.Journal of Hematology & Oncology|February 14, 2018
SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDSYumin Huang, John Hale, Yaomei Wang, et al.Haematologica|October 21, 2017
Expansion of EPOR-negative macrophages besides erythroblasts by elevated EPOR signaling in erythrocytosis mouse modelsJieyu Wang, Yoshihiro Hayashi, Asumi Yokota, et al.Blood Advances|June 16, 2018
Severely impaired terminal erythroid differentiation as an independent prognostic marker in myelodysplastic syndromesAbdullah Mahmood Ali, Yumin Huang, Ronald Feitosa Pinheiro, et al.Blood|May 26, 2021
Impairment of human terminal erythroid differentiation by histone deacetylase 5 deficiencyYaomei Wang, Wei Li, Vincent P Schulz, et al.Blood|February 8, 2017
Distinct roles for TET family proteins in regulating human erythropoiesisHongxia Yan, Yaomei Wang, Xiaoli Qu, et al.Oncotarget|November 18, 2015
Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLCZi Wang, Bianyin Ma, Hui Li, et al.Oncotarget|November 7, 2019
Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLCZi Wang, Bianyin Ma, Hui Li, et al.The Journal of Clinical Investigation|February 27, 2025
Megakaryocytes transfer mitochondria to bone marrow mesenchymal stromal cells to lower platelet activationChengjie Gao, Yitian Dai, Paul A Spezza, et al.Frontiers in Public Health|January 26, 2026
Cost-effectiveness analysis of bridge-to-transplantation temporary mechanical circulatory support versus non-bridged heart transplantationLei Yin, Xiuli An, Bin Yang, et al.Pageof 16